The CardioGenomic Testing Alliance (CGTA) is a collaborative alliance comprised of leading genomics companies and laboratories. The alliance was launched in March 2022 with the primary goal of educating heath care providers about the value of genomic testing in cardiology. Despite evolving technology and scientific guidelines from leading cardiology professional societies, utilization and awareness of genomic testing remains low among cardiovascular practitioners.
This alliance seeks to unite genomics companies, laboratories, digital health companies, advocacy groups, and key leaders in cardiology to improve clinical outcomes through education and awareness of genomic testing in cardiology.
Company Details
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- https://CardioGenomicTesting.com
- Competitors
- Elizabeth Schilling Adjust Your Sails Foundation, in-code, HCA Healthcare, Guilford-Blake Corp., Rocket Pharmaceuticals, The HCM Academy, Hypertrophic Cardiomyopathy Medical Society (HCMS), Genetic Cardiomyopathy Awareness, LMNA Cardiac, Sudden Cardiac-death Awareness Research Foundation.
Cardiogenomic Testing Alliance Questions
Cardiogenomic Testing Alliance's website is https://CardioGenomicTesting.com
Cardiogenomic Testing Alliance's LinkedIn profile is https://www.linkedin.com/company/cardiogenomic-testing-alliance
Cardiogenomic Testing Alliance's industry is
Hospitals and Health Care
Cardiogenomic Testing Alliance's top competitors are
Elizabeth Schilling Adjust Your Sails Foundation,
In-Code,
Hca Healthcare,
Guilford-Blake Corp.,
Rocket Pharmaceuticals,
The Hcm Academy,
Hypertrophic Cardiomyopathy Medical Society (Hcms),
Genetic Cardiomyopathy Awareness,
Lmna Cardiac,
Sudden Cardiac-Death Awareness Research Foundation.
Cardiogenomic Testing Alliance's categories are Hospitals and Health Care
